Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics of CYP3A: considerations for HIV treatment.

Pharmacogenomics - 1 Aug 2009

Lakhman Sukhwinder S, Ma Qing, Morse Gene D

Abstract excerpt

The understanding of the cytochrome P450 3A SNP in antiretroviral therapy is important, because it is highly inducible, extremely polymorphic and metabolizes many of the drugs that are key components of highly active antiretroviral therapy regimens. This enzyme is prolific and promiscuous towards...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active
Share to Cytochrome P-450 CYP3A

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 Enzyme System

Share to Gene Frequency

Share to HIV Infections

Share to Inactivation, Metabolic

Share to Pharmacogenetics

Source

Open in PubMed Open full text

Identifiers

PMID: 19663676
DOI: 10.2217/pgs.09.53
PMCID: PMC2776626

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19663676-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics of CYP3A: considerations for HIV treatment.PMID 19663676Read ↗

Pharmacogenetic associations with cytochrome P450 in antiretroviral therapy: what does the future hold?Semantic proximity Read ↗

Pharmacogenetic considerations for HIV treatment in different ethnicities: an update.Semantic proximity Read ↗

CYP3A4 and CYP3A5: the crucial roles in clinical drug metabolism and the significant implications of genetic polymorphismsSemantic proximity Read ↗

Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity.Semantic proximity Read ↗

Why We Need to Take a Closer Look at Genetic Contributions to CYP3A ActivitySemantic proximity Read ↗

The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition.Semantic proximity Read ↗

The missing linkage: what pharmacogenetic associations are left to find in CYP3A?Semantic proximity Read ↗

CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy.Semantic proximity Read ↗

Pharmacogenetics of anti-HIV drugs.Semantic proximity Read ↗

Pharmacogenomics of Antiretroviral Drug Metabolism and TransportSemantic proximity Read ↗

Genetic variability in CYP3A5 and its possible consequences.Semantic proximity Read ↗

Pharmacogenetics of CYP2B6, CYP2A6 and UGT2B7 in HIV treatment in African populations: focus on efavirenz and nevirapine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.